期刊文献+

MRI定量动态对比增强成像和T1WI灌注成像在鼻咽癌临床分期的应用 被引量:3

Permeability quantitative parameters of MRI quantitative dynamic contrast enhanced and perfusion parameters of T1WI perfusion imaging in the different clinical staging of nasopharyngeal carcinoma
下载PDF
导出
摘要 目的探讨MRI定量动态对比增强成像的渗透性定量参数和T1WI灌注成像灌注参数在鼻咽癌T分期和N分期的应用价值。方法比较MRI定量动态增强成像渗透性定量参数(Ktrans,Kep,Ve,Vp)和T1WI灌注成像参数(BV,BF,MTT,TTP)在鼻咽癌病例的T分期和N分期是否有统计学差异。结果本研究纳入77例鼻咽癌患者。BV和TTP在鼻咽癌T分期不同分组中有统计学差异;Ve,BF,MTT在鼻咽癌N分期不同分组中,有统计学差异。结论 MRI定量动态增强成像的渗透性定量参数和T1WI灌注成像灌注参数,可以定量化区分鼻咽癌T分期和N分期。 Objective To investigate the permeability quantitative parameters of MRI quantitative dynamic contrast enhanced imaging and the perfusion parameters of T1 WI perfusion imaging in different T staging and N staging of nasopharyngeal carcinoma.Methods Comparing permeability quantitative parameters(Ktrans, Kep, Ve, Vp,) of MRI quantitative dynamic enhanced imaging and perfusion parameters(BV, BF, MTT, TTP) of T1 WI perfusion imaging are statistically different in T and N stages of nasopharyngeal carcinoma cases. Results This study included 77 patients with nasopharyngeal carcinoma. BV and TTP are statistically different in different groups of T stage in nasopharyngeal carcinoma cases;Ve, BF, and MTT have statistical differences in different groups of N stage in nasopharyngeal carcinoma cases. Conclusion Permeability quantitative parameters of MRI quantitative dynamic enhanced imaging and perfusion parameters of T1 WI perfusion imaging can the T stage and N stage of nasopharyngeal carcinoma.
作者 孙俊旗 单菲菲 孟志华 陈振松 唐晓婷 谢静 康艺 SUN Junqi;SHAN Feifei;MENG Zhihua(Department of Radiology,Yuebei People's Hospital of Shantou University,Shaoguan,512026,China.)
出处 《江西医药》 CAS 2020年第7期801-803,809,共4页 Jiangxi Medical Journal
基金 广东省医学科学技术研究基金项目,编号B2019159 韶关市科技计划项目,编号2018sn103 韶关市卫生计生科研项目,编号Y19053 粤北人民医院优秀科研,编号201919。
关键词 鼻咽癌 磁共振成像 定量动态增强成像 灌注成像 临床分期 Nasopharyngeal carcinoma Quantitative dynamic enhanced imaging T1WI perfusion imaging Clinical staging
  • 相关文献

参考文献4

二级参考文献58

  • 1Fleming ID,Cooper JS,Henson DE,et al. AJCC cancer staging manual[M].5th ed. Philadelphia,PA:Lippincott-Raven,1997.
  • 2Sobin LH,Wittekind CH.TNM classification of malignant tumours[M].5th ed. New York,NY:Wiley-Liss,1997.
  • 3Ho JHC.Stage classification of nasopharyngeal carcinoma:a review[A]//de Teh G,Ito Y.Nasopharyngeal Carcinoma:Etiology and Control[M].Lyon,France:International Agency for Research on Cancer,1978:99-113.
  • 4Lee AWM,Foo W,Law SCK,et al. Staging of nasopharyngeal carcinoma:from Ho’s to the new UICC system[J].Int J Cancer,1999,84(2):179-187.DOI:10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6.
  • 5Greene F,Page D,Fleming I.AJCC cancer staging manual[M].6th ed. New York,NY:Springer-Verlag,2002.
  • 6Sobin LH,Wittekind C.TNM classification of malignant tumours[M].6th ed. New York,NY:Wiley-Liss,2002.
  • 7Sobin LH,Gospodarowicz MK,Wittekind C.TNM classification of malignant tumours[M].7th ed. Oxford,United Kingdom:Wiley-Blackwell,2009.
  • 8Edge S,Byrd DR,Compton CC,et al. AJCC cancer staging handbook:from the AJCC cancer staging manual[M].7th ed. New York,NY:Springer,2010.
  • 9Lee AWM,Au JSK,Teo PML,et al. Staging of nasopharyngeal carcinoma:suggestions for improving the current UICC/AJCC staging system[J].Clin Oncol (R Coll Radiol),2004,16(4):269-276.DOI:10.1016/j.clon.2004.01.008.
  • 10Low JSH,Heng DMK,Wee JTS.The question of T2a and N3a in the UICC/AJCC (1997) staging system for nasopharyngeal carcinoma[J].Clin Oncol (R Coll Radiol),2004,16(8):581-583.DOI:10.1016/j.clon.2004.08.003.

共引文献220

同被引文献34

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部